Diligence memo · auto-generated · as of July 3, 2026
Ancient Remedies, Inc.
Ancient Remedies, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Ancient Remedies, Inc. operates in Other, based in LONE TREE.
Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Ancient Remedies, Inc. has raised $650K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $350K on 2015-07-25.
Most recent recorded round closed around 2015-07-25.
Valuation (modeled)modeled
Provath models Ancient Remedies, Inc. at approximately $8.1M (range $233K–$92M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.00× the median modeled value of Pre-Seed Other companies in 2013–2015 (1650 peers) — value vs value, same stage and era. Within the normal band (100% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 547 months.
Last raise 10.9 yr ago; this sector typically re-raises about every 11 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.2× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 29% of Other peers (25015 compared).
Modeled value ranks above 35% of those peers.
Closest niche peers: Waterblue IV LLC, Fairway America Fund VI, LLC, LoanTek, Inc., Roosevelt Way Investment, L.P., West Coast Customs Inc.
Peoplefiled
7 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Broad sector classification weakens peer comparison.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.